What action will the government take in reference to the claim made by the Auditor General in his May 1995 report to Parliament that, with respect to the Drugs Directorate and Medical Devices Bureau, (a) "key issues identified in past studies still remain outstanding", and ( b ) ``many of the changes recommended-are still not fully implemented'', and what specific measures are being developed to deal with high risk products and devices?
In the House of Commons on September 18th, 1995. See this statement in context.